Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06953388 · ClinicalTrials.gov registry record · Phase 1
Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD
A Phase 1 study, sponsored by Wayne State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT06953388 is a Phase 1 study that has not yet begun recruiting, run by Wayne State University. The registered enrollment target is 60 participants.
The verdict
NCT06953388, a Phase 1 study, has not yet begun recruiting, sponsored by Wayne State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to determine how non-invasive brain stimulation (delivered through the ear called vagus nerve stimulation) affects fear learning processes in people who have experienced psychological trauma. To answer these questions, we measure bodily responses (heart rate, sweat, startle) and questionnaires. The main questions it aims to answer are: Does non-invasive vagus nerve stimulation help reduce anxious arousal? Does non-invasive vagus nerve stimulation help dampen learned fear?
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation
- DEVICE sham transcutaneous auricular vagus nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2032-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06953388
The ClinicalTrials.gov registry entry for NCT06953388 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation is the first listed.
NCT06953388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06953388 about?
NCT06953388 is a clinical study titled "Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD". The goal of this study is to determine how non-invasive brain stimulation (delivered through the ear called vagus nerve stimulation) affects fear learning processes in people who have experienced psychological trauma. To answer these questions, we measure bodily responses (heart rate, sweat, startle...
What is the current status of trial NCT06953388?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2026-02-01. Estimated completion is 2032-12.
What interventions are being tested in trial NCT06953388?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation (DEVICE), sham transcutaneous auricular vagus nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT06953388?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.